drugset / Trial / NCT06682637
Melflufen for Elderly Patients With Relapsed Myeloma
NaSingle-groupOpen-labelOther
Summary
This is a pilot study aimed to evaluate the efficacy and tolerability of melflufen plus dexamethasone in elderly patients at second relapse. Thirty elderly patients at second or subsequent relapse.
Timeline
- Start
- 2025-03-26
- Primary completion
- 2025-03-26
- Completion
- 2025-03-26
Outcome
Outcome not reported
Stopped: “Clinical trial never activated, not authorized by CA”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melphalan flufenamide | Peptide | 30 mg | Intravenous |
| Subject | Melphalan flufenamide | Peptide | 40 mg | Intravenous |
| Background | Dexamethasone | Small molecule | 10 mg | Oral |
Indications
No indication recorded.